Injective (INJ) has climbed 25% in a single day, fueled by intense demand in both spot and derivatives markets. This surge occurs alongside a broader rally in the AI and big data token sector, which has risen nearly 9%.
The 8.87% lift in AI and big data tokens
The recent price action for Injective is not an isolated event but appears to be part of a wider movement within specialized crypto niches. as reported by CoinMarketData, the entire AI and big data token sector has seen a significant performance boost, climbing 8.87% in a 24-hour window. this suggests that capital is currently rotating into assets that promise intersectional utility between blockchain and artificial intelligence.
Injective’s 30% weekly gain and its 70% climb over the last month indicate that it is a primary beneficiary of this sector-wide enthusiasm. While the broader market often dictates the direction of altcoins, the specific strength of the AI-related tokens suggests that investors are looking for thematic plays rather than general market exposure.
Breaking through the $6.93 to $9.17 supply zone
From a technical perspective, Injective has successfully navigated a difficult price landscape. For several months, the area between $6.93 and $9.17 acted as a significant bearish breaker block, serving as a supply zone that effectively capped the token's upside since November. While this range briefly acted as a demand zone during the market sell-off in October, the current breakout signals a fundamental shift in market sentiment.
The report says that the breakout past the $8.50 level on the H4 timeframe has confirmed strong bullish momentum . This move is being reinforced by technical indicators, specifically the Relative Strength Index (RSI) and the On-Balance Volume (OBV), which suggest that the current upward trajectory has sufficient strength behind it to move beyond previous resistance levels.
The $9.60 weekly close and the $13.575 target
Despite the current momentum, several key price levels will determine if this is a sustained trend or a temporary spike. Traders are closely watching the $9.60 mark; a weekly session close above this level would provide the necessary confirmation for a bullish continuation. Without that weekly close, the current rally may struggle to maintain its footing against historical resistance.
For long-term investors, the roadmap is even more ambitious. While swing traders may look for buying opportunities during pullbacks to the $8.50 level, the ultimate confirmation of a permanent trend change requires Injective to break past $13.575. Reaching this milestone would signal that the token has moved into a new market regime entirely.
Will real usage justify the Revenue/FDV ratio?
A significant question remains regarding whether this price appreciation is anchored in fundamental utility or speculative fervor. The source notes that the Revenue/FDV (Fully Diluted Valuation) ratio is one of the most critical metrics for determining if a network's valuation is actually backed by real usage.
While the current surge is driven by spot and derivatives demand, it is still unclear if the underlying network activity of Injective can scale at the same rate as its market capitalization. If the revenue generated by the network does not begin to catch up with the rising valuation, the current rally could face significant headwinds from investors looking for more fundamental value.
Comments 0